Ardelyx, Inc.
Current role
ARDX
James Brady
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Brady
James Brady was last confirmed as Board Member at Xeris Biopharma Holdings, Inc. (XERS) in a filing dated April 23, 2025. Xeris Biopharma Holdings, Inc. reported in an 8-K filed March 28, 2025 that James Brady was appointed director, effective March 28, 2025.
“On March 28, 2025, the Board appointed Mr. James Brady to the Company's Board, effective on such date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Ardelyx, Inc. (ARDX)
Proxy statement
CurrentStart not stated–present
-
2025-01-01–2025-04-23
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Ardelyx, Inc.
Other people whose current roles at this company are on record from its filings.
- Michael Raab CEO, Board Member
- Keith Santorelli CFO
- Susan Hohenleitner CFO
- Joseph Reilly Chief Accounting Officer
- Justin Renz Chief Accounting Officer
- Robert Felsch Chief Accounting Officer
- David Mott Board Member
- Merdad Parsey, M.D., Ph.D Board Member
- Muna Bhanji Board Member
- Muna Bhanji, R.Ph Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.